mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.4 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
FMK |
GDSC1000 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.4 |
mRNA |
A-770041 |
GDSC1000 |
pan-cancer |
AAC |
-0.046 |
0.4 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
-0.029 |
0.4 |